S&P 500

5.447,87

-0,31%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Maxpro Capital Acquisition Corporation (JMACU)
Maxpro Capital Acquisition Corporation (JMACU) Notícias

JMACU

Maxpro Capital Acquisition (JMACU)

Maxpro Capital Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:JMACU

1

Data	Hora	Fonte	Título	Código	Companhia
10/04/2023	10:01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
31/03/2023	17:01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
30/03/2023	09:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
29/03/2023	18:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
29/03/2023	17:25	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/02/2023	18:56	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
13/01/2023	18:13	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
10/01/2023	18:32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
10/01/2023	18:05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
15/11/2022	10:00	GlobeNewswire Inc.	Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/09/2022	09:30	GlobeNewswire Inc.	Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
14/02/2022	18:15	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
26/11/2021	11:00	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
13/10/2021	19:03	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
13/10/2021	14:10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
07/10/2021	19:41	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation